Showing 1591-1600 of 2050 results for "".
- Applications Being Accepted for the 2025 Ramin Tadayoni Awardhttps://modernod.com/news/applications-being-accepted-for-the-2025-ramin-tadayoni-award/2482740/Oculis, in collaboration with EURETINA, announced that applications are now being accepted for the 2025 Ramin Tadayoni Award. The Ramin Tadayoni Award continues its legacy through EURETINA and has been supported by Oculis as a lasting tribute
- FDA Clears New World Medical's VIA360 Surgical Systemhttps://modernod.com/news/fda-clears-new-world-medicals-via360-surgical-system/2482667/New World Medical has received 510(k) clearance from the FDA for its VIA360 Surgical System for the delivery of controlled amounts of viscoelastic fluid during ophthalmic surgeries. The VIA360, which is also indicated to cut trabecular meshwork tissue during trabecul
- Reports: New Round of Layoffs at FDA and CDChttps://modernod.com/news/reports-new-round-of-layoffs-at-fda-and-cdc/2482666/The FDA has initiated layoffs across multiple divisions at the FDA and Centers for Disease Control and Prevention (CDC), according to news reports. According to internal
- Kala Bio Announces Chief Executive Officer Transitionhttps://modernod.com/news/kala-bio-announces-chief-executive-officer-transition/2482662/Kala Bio announced the resignation of Chief Executive Officer Mark Iwicki, and the appointment of Todd Bazemore, Kala's President and Chief Operating Officer, as interim CEO, effective immediately. Mr. Iwicki will continue to serve as Chair of the Board of Directors of Kala fol
- DigitalOptometrics to Preview 'World’s First Autonomous Slitlamp' at Vision Expo East 2025https://modernod.com/news/digitaloptometrics-to-preview-worlds-first-autonomous-slitlamp-at-vision-expo-east-2025/2482655/DigitalOptometrics has announced the launch of what it is calling the world’s first and most advanced autonomous slitlamp with remote control capabilities at Vision Expo East (VEE) 2025 in Orlando. In collaboration with SlitLED, DigitalOptometrics will demonstrate t
- Pantheon Vision Advances Corneal Implant Developmenthttps://modernod.com/news/pantheon-vision-advances-corneal-implant-development/2482627/Pantheon Vision announced the completion of its third meeting with the FDA review team as the company continues its development of bioengineered corneal implants, designed to address the global challenge of corneal blindness. Over the past year, Pan
- RayOne EMV Toric IOL Approved by Health Canadahttps://modernod.com/news/rayone-emv-toric-iol-approved-by-health-canada/2482626/Rayner announced the approval of RayOne EMV Toric IOL by Health Canada. Developed in collaboration with Professor Graham Barrett, RayOne EMV and RayOne EMV Toric are the only patented aspheric IOLs that induce controlled positive spherical aberration to extend depth of focus, according
- Visible Genomics Wins 2025 AMD Genetic Testing Company of the Year Awardhttps://modernod.com/news/visible-genomics-wins-2025-amd-genetic-testing-company-of-the-year-award/2482619/Visible Genomics, a provider of genetic testing solutions for severe ocular diseases, was named 'Life Sciences Review AMD Genetic Testing Company of the Year 2025.' This award recognizes the company’s innovative contributions to proactive care for advanced age-related macular degene
- Tangible Science Announces CEO Transitionhttps://modernod.com/news/tangible-science-announces-ceo-transition/2482613/Tangible Science, a provider of specialty contact lens technology, announced that Karen Havenstrite, PhD, MBA, co-founder and former Chief Technology Officer, has been appointed Chief Executive Officer. Dr. Havenstrite suceeds Victor McCray, MD, who will transition to the
- UC Irvine Scientists Find DNA Damage is Key Factor in AMDhttps://modernod.com/news/uc-irvine-scientists-find-dna-damage-is-key-factor-in-amd/2482569/Accumulated DNA damage in the retina is a key contributor to age-related macular degeneration (AMD) and that targeting specific retinal cell types may lead to treatments that slow or stop progression, according to a research team co-led by the University of California, Irvine. The